206 related articles for article (PubMed ID: 24587032)
1. Rab27a was identified as a prognostic biomaker by mRNA profiling, correlated with malignant progression and subtype preference in gliomas.
Wang H; Zhao Y; Zhang C; Li M; Jiang C; Li Y
PLoS One; 2014; 9(2):e89782. PubMed ID: 24587032
[TBL] [Abstract][Full Text] [Related]
2. RAB38 confers a poor prognosis, associated with malignant progression and subtype preference in glioma.
Wang H; Jiang C
Oncol Rep; 2013 Nov; 30(5):2350-6. PubMed ID: 24026199
[TBL] [Abstract][Full Text] [Related]
3. BMP4, a strong better prognosis predictor, has a subtype preference and cell development association in gliomas.
Bao Z; Zhang C; Yan W; Liu Y; Li M; Zhang W; Jiang T
J Transl Med; 2013 Apr; 11():100. PubMed ID: 23590708
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of a nine-gene signature in glioma patients based on mRNA expression profiling.
Bao ZS; Li MY; Wang JY; Zhang CB; Wang HJ; Yan W; Liu YW; Zhang W; Chen L; Jiang T
CNS Neurosci Ther; 2014 Feb; 20(2):112-8. PubMed ID: 24279471
[TBL] [Abstract][Full Text] [Related]
5. RAB34 was a progression- and prognosis-associated biomarker in gliomas.
Wang HJ; Gao Y; Chen L; Li YL; Jiang CL
Tumour Biol; 2015 Mar; 36(3):1573-8. PubMed ID: 25501506
[TBL] [Abstract][Full Text] [Related]
6. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
[TBL] [Abstract][Full Text] [Related]
7. High expression of RAB43 predicts poor prognosis and is associated with epithelial-mesenchymal transition in gliomas.
Han MZ; Huang B; Chen AJ; Zhang X; Xu R; Wang J; Li XG
Oncol Rep; 2017 Feb; 37(2):903-912. PubMed ID: 28075478
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of ion channel genes in Chinese patients with gliomas based on mRNA expression profiling.
Lu FF; Wang HY; He XZ; Liang TY; Wang W; Hu HM; Wu F; Liu YW; Zhang SZ
J Neurooncol; 2017 Sep; 134(2):397-405. PubMed ID: 28752501
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of MEOX2 in gliomas.
Tachon G; Masliantsev K; Rivet P; Petropoulos C; Godet J; Milin S; Wager M; Guichet PO; Karayan-Tapon L
Mod Pathol; 2019 Jun; 32(6):774-786. PubMed ID: 30659268
[TBL] [Abstract][Full Text] [Related]
10. Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.
Cheng W; Li M; Jiang Y; Zhang C; Cai J; Wang K; Wu A
J Neurosurg; 2016 Jul; 125(1):7-16. PubMed ID: 26544773
[TBL] [Abstract][Full Text] [Related]
11. ZEB1 expression is increased in IDH1-mutant lower-grade gliomas.
Nesvick CL; Zhang C; Edwards NA; Montgomery BK; Lee M; Yang C; Wang H; Zhu D; Heiss JD; Merrill MJ; Ray-Chaudhury A; Zhuang Z
J Neurooncol; 2016 Oct; 130(1):111-122. PubMed ID: 27568035
[TBL] [Abstract][Full Text] [Related]
12. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
[TBL] [Abstract][Full Text] [Related]
13. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of mitochondrial pyruvate carrier in isocitrate dehydrogenase-mutant glioma.
Karsy M; Guan J; Huang LE
J Neurosurg; 2018 Mar; 130(1):56-66. PubMed ID: 29547090
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA LINC00152 is a potential prognostic biomarker in patients with high-grade glioma.
Wang W; Wu F; Zhao Z; Wang KY; Huang RY; Wang HY; Lan Q; Wang JF; Zhao JZ
CNS Neurosci Ther; 2018 Oct; 24(10):957-966. PubMed ID: 29577647
[TBL] [Abstract][Full Text] [Related]
16. Stanniocalcin 1 is a prognostic biomarker in glioma.
Luo W; Chen D; Wang H; Hu J
Oncol Lett; 2020 Sep; 20(3):2248-2256. PubMed ID: 32782542
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
Dahlrot RH
Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor beta induced (TGFBI) is a potential signature gene for mesenchymal subtype high-grade glioma.
Pan YB; Zhang CH; Wang SQ; Ai PH; Chen K; Zhu L; Sun ZL; Feng DF
J Neurooncol; 2018 Apr; 137(2):395-407. PubMed ID: 29294230
[TBL] [Abstract][Full Text] [Related]
19. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas.
Zhao WJ; Ou GY; Lin WW
Front Immunol; 2021; 12():682415. PubMed ID: 34054873
[TBL] [Abstract][Full Text] [Related]
20. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas.
Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH
Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
